ceftolozane

Ceftolozane, also known as FR-264,205 and CXA-101; is an antibiotic drug from the cephalosporin family, approved for the treatment of infections with gram-negative bacteria, or gram-positive bacteria. Ceftolozane is of great benefit due to its ability to target bacteria that have become resistant to conventional antibiotics. Ceftolozane is combined with the β-lactamase inhibitor tazobactam, as multi-drug resistant bacterial infections will generally show resistance to all β-lactam antibiotics unless this enzyme is inhibited. .

Ceftolozane TFA is a cephalosporin class antibiotic (antibiotic) designed to inhibit Gram-negative bacterial infections. Additionally, it can be utilized in the synthesis of novel antibiotics (antibiotic) that are more efficacious and safer.

Ceftolozane-15N2,d4 (CXA-101-15N2,d4) TFA is a 15N and deuterium-labeled form of Ceftolozane TFA. This compound is a cephalosporin-class antibiotic (antibiotic) used to inhibit infections caused by Gram-negative bacteria. Additionally, Ceftolozane TFA can be applied in the synthesis of new antibiotics that offer enhanced potency and safety.

Ceftolozane sulfate (FR-264205/CXA-101) is a cephalosporin antibiotic, a penicillin-binding protein (PBP) inhibitor with antipseudomonal activity, used for infection research including pneumonia.

Ceftolozane-[D4.15N2] Trifluoroacetate Salt (Standard) is a reference standard of Ceftolozane-[D4.15N2] Trifluoroacetate Salt intended for quantitative analysis, quality control, and related biochemical research applications.